Agios to present at the td cowen 45th annual healthcare conference on march 3, 2025

Cambridge, mass., feb. 20, 2025 (globe newswire) -- agios pharmaceuticals, inc. (nasdaq: agio), a leader in cellular metabolism and pk activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the td cowen 45th annual healthcare conference on monday, march 3, 2025, at 10:30 a.m. et.
COWN Ratings Summary
COWN Quant Ranking